John Paulson’s Q3 2025 13F portfolio surged to ~$2.97B, concentrated in just 10 securities, with Madrigal Pharma (MDGL) as the largest position. MDGL, now ~30% of the portfolio, was trimmed by ~9% but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results